Reading time: 10 minutes
Cardiovascular disease is the leading cause of death globally. Leading Chinese cardiovascular centres — Fuwai Hospital, Beijing Anzhen Hospital, Zhongshan Hospital of Fudan University, West China Hospital Cardiology, Guangdong Provincial People’s Hospital Cardiovascular Institute, and others — operate cardiovascular imaging and diagnostic capability at par with leading Western centres, with pricing typically 30–50% of US levels. The same principle as in the health-check article (Article #71) applies here: the value of cardiovascular screening depends on doing the right test on the right person — more is not better. This article uses the ACC/AHA and USPSTF risk-stratification frameworks [1][2] to clarify which tests fit which patients, the typical process, and the costs.
1. Cardiovascular Risk Stratification (Answer This Question First)
Using the ACC/AHA Pooled Cohort Equations to estimate 10-year ASCVD risk:
| Risk tier | 10-year ASCVD risk | Screening recommendation |
|---|---|---|
| Low | < 5% | Basic screening (BP, lipids, glucose, BMI) |
| Borderline | 5–7.5% | Consider coronary artery calcium (CAC) to refine decision |
| Intermediate | 7.5–20% | CAC and further testing as indicated |
| High | ≥ 20% | Initiate secondary prevention; imaging has specific indications |
ACC/AHA position: beyond basic screening, coronary artery calcium (CAC) is the most evidence-based step-up screening tool for asymptomatic adults [1].
2. Sensible Placement of Each Test
1. Coronary artery calcium (CAC, Calcium Score CT)
- Low-dose non-contrast chest CT, takes about 5 minutes
- Agatston score 0–400+
- Value: refines cardiovascular risk and informs statin initiation decisions
- Appropriate for: ages 40–75, borderline-to-intermediate risk, family history, diabetes, smokers
- Not appropriate: asymptomatic young adults at low risk
2. Coronary CT angiography (CCTA)
- Contrast-enhanced CT showing coronary stenoses
- Value: defines anatomy, identifies stenoses warranting further intervention
- Appropriate for: symptomatic chest pain workup, evaluation of high CAC scores, intermediate-to-high-risk patients
- Not appropriate: routine screening of asymptomatic low-risk individuals
3. Stress testing
- Exercise treadmill ECG, exercise stress echo, or exercise nuclear myocardial perfusion
- Value: provoked functional ischaemia evaluation
- Appropriate for: symptomatic patient evaluation, intermediate-risk patients
- Not appropriate: asymptomatic low-risk routine screening
4. Cardiac MRI (CMR)
- High-resolution imaging assessing myocardium, pericardium, ventricular function, and myocardial fibrosis
- Value: cardiomyopathy, myocarditis, complex congenital heart disease, cardiac tumour evaluation
- Appropriate for: specific clinical questions
- Not appropriate: routine health screening
5. Carotid ultrasound
- Value: carotid intima-media thickness (IMT) and plaque identification, reflecting systemic atherosclerotic burden
- Appropriate for: adjunct risk stratification in intermediate-risk patients
- Not appropriate: routine in low-risk individuals
6. 24-hour Holter / 7-day event monitor
- Appropriate for: evaluation of symptomatic arrhythmias
- Not appropriate: asymptomatic routine screening
3. Hospitals to Consider
Cardiovascular specialty hospitals and general hospital cardiology departments:
| Hospital | City |
|---|---|
| Fuwai Hospital, Chinese Academy of Medical Sciences | Beijing |
| Beijing Anzhen Hospital, Capital Medical University | Beijing |
| Zhongshan Hospital of Fudan University, Cardiology | Shanghai |
| Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Cardiology | Shanghai |
| West China Hospital, Cardiology | Chengdu |
| Guangdong Provincial People’s Hospital, Cardiovascular Institute | Guangzhou |
| Peking University First Hospital, Cardiology | Beijing |
| Renmin Hospital of Wuhan University, Cardiology | Wuhan |
4. Typical Process
Cardiovascular deep screening package (2–3 days):
- Day 1: cardiology specialist consultation, ECG, lipid panel, echocardiogram, stress testing as indicated
- Day 2: CAC and/or CCTA as indicated
- Day 3: integrated report review and secondary prevention plan
5. Typical Costs (USD, 1 USD = 6.5 RMB)
| Item | Public tertiary international dept. | High-end private |
|---|---|---|
| Cardiology specialist consultation | 80–250 | 150–500 |
| Comprehensive lipid panel + ApoB + Lp(a) | 80–200 | 150–400 |
| ECG | 15–40 | 30–80 |
| 24-hour Holter | 80–200 | 150–400 |
| Transthoracic echocardiogram | 100–250 | 200–500 |
| Exercise treadmill test | 100–250 | 200–500 |
| Exercise stress echo | 200–500 | 400–900 |
| Nuclear myocardial perfusion (SPECT) | 600–1,500 | 1,000–2,500 |
| Coronary artery calcium (CAC) | 200–500 | 400–800 |
| Coronary CT angiography (CCTA) | 600–1,500 | 1,000–2,500 |
| Cardiac MRI (CMR) | 700–1,800 | 1,200–2,800 |
| Carotid ultrasound | 80–200 | 150–400 |
US reference: CAC USD 100–400; CCTA USD 700–2,000; CMR USD 1,000–3,000; Holter USD 200–600 [3].
6. A Few Plain Words on “Cardiac Check Packages”
- Do not be drawn by “full cardiac + PET + MRI + genetic” bundle marketing — most of these items have no evidence in asymptomatic low-risk individuals
- CAC is the highest-yield “additional item” at the price (USD 200–500)
- Any “abnormal finding” in a cross-border setting should be decided on by your home-country physician regarding whether to intervene
7. What MedCareInChina Can and Cannot Do on the Cardiovascular Screening Pathway
Our two products are Remote Consultation and In-China Accompanied Care.
- Remote Consultation: USD 800 single-expert consultation. Before travelling, a cardiologist can assess your risk and design a sensible package; after screening, results can be interpreted remotely
- In-China Accompanied Care: full accompaniment and translation through investigations and report review
What we do not do: long-term cardiovascular risk management, secondary prevention drug follow-up.
8. Action Checklist
- Use the ACC/AHA Risk Estimator (public online tool) to calculate your 10-year ASCVD risk
- Confirm with your home-country physician whether step-up imaging is actually warranted
- Engage a remote consultation to design a sensible package
- Apply for an S2 visa
- Plan 2–3 days in China
- Abnormal findings are decided on by your home-country physician
Sources
[1] American Heart Association / American College of Cardiology — Primary Prevention Guidelines and CAC use: https://www.ahajournals.org/ [2] US Preventive Services Task Force — Cardiovascular screening recommendations: https://www.uspreventiveservicestaskforce.org/ [3] HealthCare Cost Institute — Cardiac imaging cost benchmarks: https://healthcostinstitute.org/ [4] National Lipid Association — Recommendations: https://www.lipid.org/ [5] European Society of Cardiology — Prevention Guidelines: https://www.escardio.org
